Tag: Weight Loss
Few Adolescents With Obesity Prescribed Obesity Medications
0.5 percent with obesity were prescribed an obesity medication in 2023; 83 percent of prescriptions received by teens with severe obesity
Real-World Weight Loss With Semaglutide, Tirzepatide Less Than That Seen in Clinical Trials
In real-world cohort, percentage weight reduction at one year was 3.6, 6.8, and 11.9 percent with early and late discontinuation and nondiscontinuation, respectively
Less ‘Experienced Weight Stigma’ After Bariatric Surgery Aids Mental Health
Changes from pre- to post-metabolic bariatric surgery weight stigma predict mental health, dysregulated eating, body mass index
Plant-Based Diet Tied to Weight Loss, Fewer Hot Flashes in Postmenopausal Women
Findings seen regardless of the level of processing of the plant-based diet
Semaglutide Plus Intensive Behavioral Therapy Most Beneficial for Weight Loss
Strong outcomes seen in terms of weight loss, with lower doses of semaglutide used
FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs
First Weight-Loss Pill From Lilly Shows Promising Results
Tirzepatide Dispensations Increased Rapidly After Approval
By December 2023, 12.3 percent of all glucose-lowering medication dispensations were tirzepatide among adults with T2DM
Pfizer Ends Testing of Obesity Pill After Possible Liver Injury
2018 to 2022 Saw Increase in GLP-1 Receptor Agonist Use in Adults Without Diabetes
Pooled annual prevalence of GLP-1 RA use was 0.1 percent from 2018 to 2021 and increased to 0.4 percent by 2022
